News

ICLR LAWSUIT ALERT: Levi & Korsinsky Notifies ICON Public Limited Company Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / April 10, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to ...
ICON Public Limited Company (ICLR) Slid on Drop in Biotechnology Funding
"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from ...
Hosted on MSN22d
Is ICON Public Limited Company (ICLR) the Best Diagnostics Stock to Invest in Right Now?
ICON Public Limited Company (NASDAQ:ICLR) is a clinical research organization that provides outsourced development services to the biotechnology, pharmaceutical, and medical device industries. It ...
Icon Plc: The Sale Was Well-Timed
We purchased shares of Icon in March 2024 for ~$323.00 per share. Why did we sell our ICLR position and move on? Click here ...